Defibrillators are cardiovascular devices that deliver therapeutic doses of electrical energy in the form of electric shocks to the heart muscles to restore the heartbeat to a normal rhythm. Defibrillators are used for the treatment of life-threatening cardiac dysphasia, pulses ventricular tachycardia, and ventricular fibrillation. They are also used for controlling irregular heart rhythm, preventing heart failure, and treating patients at risk for sudden cardiac arrest.
In the process of defibrillator, an electric shock Is delivered to the heart, which depilatories the heart muscles and re- establishes the normal conduction of electrical Impulses In the heart. Covered In this Report This report covers the present scenario and the growth prospects of the Global Defibrillator market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of the following types of product: Advanced life support defibrillators
Wearable defibrillators View our full TCO here Key Regions Americas Key Vendors BIOTIN Gumbo & co. KEG Boston Scientific Corp.. Monitored Inc. Philips Healthcare SST. Jude Medical Inc. Other Prominent Vendors Slash Sakes Defected GE Healthcare Hearting Technologies Onion Sodden Physic-Control Schaller Scorn Key Market Driver Increase in Incidence of Cardiac Disorders For a full, detailed list, view our report. Key Market Challenge Safety Concerns Associated with Defibrillators Key Market Trend
Increase in Use of Multifunction Defibrillators Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? For more insights, view our Global Defibrillator Market 2014-2018 report.